Eldon Scott Priestley
Bristol-Myers Squibb
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Eldon Scott Priestley.
Bioorganic & Medicinal Chemistry Letters | 2017
Xiaojun Zhang; Peter W. Glunz; Eldon Scott Priestley; James A. Johnson; Nicholas R. Wurtz; Vladimir Ladziata
A series of macrocyclic factor XIa (FXIa) inhibitors was designed based on an analysis of the crystal structures of the acyclic phenylimidazole compounds. Further optimization using structure-based design led to inhibitors with pM affinity for FXIa, excellent selectivity against a panel of relevant serine proteases, and good potency in the activated partial thromboplastin time (aPTT) clotting assay.
Archive | 2002
Eldon Scott Priestley; Carl P. Decicco; Thomas W. Hudyma; Xiaofan Zheng
Archive | 2003
Eldon Scott Priestley; Carl P. Decicco; Thomas W. Hudyma; Xiaofan Zheng
Archive | 2001
Eldon Scott Priestley; Carl Decicco
Archive | 2007
Eldon Scott Priestley; Daniel L. Cheney; Nicholas R. Wurtz; Peter W. Glunz
Archive | 2006
Xiaojun Zhang; Eldon Scott Priestley; Alexandra A. Nirschl; Yan Zou
Archive | 2006
Xiaojun Zhang; Alexandra A. Nirschl; Yan Zou; Eldon Scott Priestley
Archive | 2013
Alain Martel; François Tremblay; Anne Marinier; Eldon Scott Priestley; Shoshana Posy; R. Michael Lawrence; Michael M. Miller
Archive | 2007
Nicholas R. Wurtz; Eldon Scott Priestley; Daniel L. Cheney; Xiaojun Zhang; Brandon Parkhurst; Vladimir Ladziata
Circulation | 2017
Pancras C. Wong; Carol A. Watson; Jeffery Bostwick; Jacques Banville; Ruth R. Wexler; Eldon Scott Priestley; Anne Marinier; Michel Bouvier; David A. Gordon; William A. Schumacher; Jing Yang
